Exploring nagZ as a virulence biomarker and treatment target in Enterobacter cloacae
BMC Microbiology · 2025
DOI: 10.1186/s12866-024-03718-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Microbiology, 2025. Verfasst von Xianggui Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, 400010, P.R. China. Hauptthemen laut MEDLINE: Enterobacter cloacae, Enterobacteriaceae Infections, Anti-Bacterial Agents, Larva. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Natural Science Foundation of Sichuan, China, the Chengdu Municipal Health Commission, China.
Abstract (Originalsprache)
BACKGROUND: Enterobacter cloacae is increasingly prevalent and resistant to multiple antibiotics, making it a significant pathogen in healthcare settings with high mortality rates. However, its pathogenic mechanisms are not fully understood. RESULTS: In this study, we explored the role of nagZ in regulating the virulence of E. cloacae and its potential as a therapeutic target. Our research showed that pathogenic strains of E. cloacae express higher levels of nagZ than colonizing strains, particularly in simulated infection environments. Deleting nagZ significantly reduced E. cloacae virulence in various infection models, including Galleria mellonella larvae, mice, and RAW264.7 cells. Moreover, nagZ knockout decreased the bacterium's ability to induce inflammatory factor levels, while complementing nagZ in knockout strains partially rescued this ability. Importantly, the absence of nagZ also enhanced the antibacterial efficacy of ceftazidime against E. cloacae. CONCLUSIONS: These findings underscore the crucial role of nagZ in E. cloacae pathogenesis and highlight its potential as a novel therapeutic target for treating infections caused by this pathogen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, 400010, P.R. China.
- Department of Laboratory Medicine, Clinical Medical College and the First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, 610500, P.R. China.
- Institute for Heart and Brain Health, University of Michigan Medical Center, Ann Arbor, MI, 48109, USA.
- Department of Clinical Laboratory, the First Affiliated Hospital of Army Medical University, Chongqing, 400038, P.R. China.
- Department of Laboratory Medicine, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, 400010, P.R. China. 300801@cqmu.edu.cn.
Förderung
- the Natural Science Foundation of Sichuan, China
- the Chengdu Municipal Health Commission, China
Zitieren
APA
Yang, X., Yu, X., Zhou, L., Wang, D., & Chen, W. (2025). Exploring nagZ as a virulence biomarker and treatment target in Enterobacter cloacae. BMC Microbiology. https://doi.org/10.1186/s12866-024-03718-2
Vancouver
Yang X, Yu X, Zhou L, Wang D, Chen W. Exploring nagZ as a virulence biomarker and treatment target in Enterobacter cloacae. BMC Microbiology. 2025. doi:10.1186/s12866-024-03718-2
BibTeX
@article{Yang2025,
author = {Yang, Xianggui and Yu, Xuejing and Zhou, Li and Wang, Dan and Chen, Weixian},
title = {Exploring nagZ as a virulence biomarker and treatment target in Enterobacter cloacae},
journal = {BMC Microbiology},
year = {2025},
doi = {10.1186/s12866-024-03718-2}
}
EUVIMED